Wording of Helicobacter pylori eradication therapy in selected summary-of-product-characteristics sections

  • Email
  • Help
Current effective version

Points to consider

Reference numberCPMP/EWP/863/98
Effective from01/03/2000
KeywordsHelicobacter pylori, summary of product characteristics (SmPC), non-NSAID induced gastro-duodenal ulcers
DescriptionThis document gives general consideration to the clinical evaluation of medicinal products intended for use in H. pylori eradication therapy. It provides guidance on the information to be included in the summary of product characteristics for these medicines.

Related content

How helpful is this page?

Average rating:

 Based on 10 ratings

Add your rating:

See all ratings
2 ratings
2 ratings
2 ratings
2 ratings
2 ratings

Tell us more